Loading...
Home2023-03-21T14:40:48+02:00

With its in-depth understanding of human stem cells and its proprietary technology of haploid human embryonic stem cells, NewStem intends to change the paradigm of life sciences and the way we develop therapeutics and diagnostics.

Our Technology

NewStem provides new groundwork for numerous biomedical applications in advanced cancer research. With the combined advantages of haploid genetics and pluripotency, Haploid human ESCs now pave the way for numerous new biomedical applications. Our HhESCs exhibited typical pluripotent stem cell characteristics, such as self-renewal capacity and a pluripotency specific molecular signature, meaning they are able to differentiate into many other cell types, including nerve, heart, and pancreatic cells, while retaining a single set of chromosomes.

Medicine icon

Therapeutics

Treating the UnTreatable

Diagnostics icon

Diagnostics

Haploid human ESC: The Clear 23

Our Technology at a Glance

Publications

Partnership Opportunities

NewStem prioritizes selective collaborations with strategic companies and promising start-ups, aimed at leveraging NewStem’s proprietary technology of haploid human embryonic stem cells (HhESC) and our in-depth understanding of human stem cells for the development of advanced and novel solutions for unmet medical needs.

Go to Top